Login / Signup

Recurrent bloodstream infections after allogeneic hematopoietic cell transplantation.

Mobil AkhmedovGalina KlyasovaLarisa KuzminaElena Parovichnikova
Published in: Expert review of anti-infective therapy (2022)
In view of low rate of recurrent BSI due to identical pathogen, empirical antimicrobial therapy should not be based on data on previous BSI episodes.
Keyphrases
  • stem cell transplantation
  • staphylococcus aureus
  • bone marrow
  • electronic health record
  • big data
  • candida albicans
  • hematopoietic stem cell
  • low dose
  • artificial intelligence
  • replacement therapy